CEFALY@Work is an innovative workplace wellness program developed by CEFALY Technology to address the widespread impact of migraine in professional settings. By integrating the company’s FDA-cleared, drug-free neuromodulation device into corporate health offerings, CEFALY@Work allows employers to offer clinically proven migraine prevention and relief directly to their teams. This marks a pioneering step in merging medtech solutions with corporate wellness, giving employers new tools to proactively support employees suffering from a commonly misunderstood yet highly disabling neurological condition.

The importance of this initiative lies in its ability to reduce the often invisible toll migraines take on employee well-being and company performance. Migraines are one of the leading causes of workplace absenteeism and presenteeism, with affected employees losing an average of four workdays per year and often underperforming during attacks. CEFALY@Work combats these challenges by providing employees with access to non-invasive treatment, personalized coaching, and stress management tools — all designed to empower them to manage symptoms discreetly and effectively on the job.

Through its three-tiered program structure, CEFALY@Work gives employers flexible options for participation — from basic discounts to fully sponsored devices and enterprise-level support. The program not only helps reduce healthcare costs and improve retention, but also destigmatizes migraine by promoting a culture of understanding and proactive care. As CEFALY Technology continues to expand its partnerships with U.S. companies, CEFALY@Work is poised to become a model for how businesses can address chronic health conditions that directly affect productivity, morale, and workforce sustainability.

MedTech Spectrum's Summary

Addresses a Critical Workplace Health Issue: CEFALY@Work offers a proactive solution for managing migraine, a top cause of lost productivity and long-term disability, especially among women.

Delivers Drug-Free, Clinically Proven Relief: The program provides access to CEFALY’s FDA-cleared neuromodulation device, helping employees prevent and relieve migraines without the side effects of medication.

Enhances Employee Well-being and Organizational Performance: By reducing migraine-related absenteeism and presenteeism, CEFALY@Work supports healthier, more productive workplaces while lowering healthcare costs.